China’s largest bubble tea and drinks firm, Mixue Group, is seeking to raise HK$3.45 billion ($443.66 million) in a Hong Kong initial public offering, a regulatory filing showed on Friday.
Featured Posts Title
China extends visa-free entry to more than 70 countries to draw tourists
China Shuns Costly LNG Imports Even as Summer Power Demand Rises
Australia’s Albanese confirms China visit as Beijing eyes trade deal review
China’s Huayou Cobalt Sees Record Profit Boosted by Indonesia
Utah’s House Speaker rallies to support Utah doctor federally charged in COVID-19 vaccine scheme
Did Trump strike a deal with China about TikTok? Here’s what we know
Shenzhen Warns Public on Fake Stablecoin Schemes
Recent Posts
China’s largest bubble tea chain Mixue aims to raise $443M in Hong Kong IPO
Mainland China courts rule crypto has no legal currency or protection status in investor dispute
China’s Jiangsu Provincial High People’s Court recently released information about a foreign-related case involving a 15.74M yuan cryptocurrency contract gone bad between Singaporean investor, Pan …
Moderna and Other Vaccine Stocks Climb After Coronavirus News From China
Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday. Shares of Moderna (MRNA), Pfizer (PFE) and Novavax (NVAX) all gained Friday, a broadly downbeat session that saw the…
The U.S’s chipmaking sector is ringing the alarm about Washington’s chip war with China
Recent earnings reports from manufacturers like Applied Materials and Lam Research show the U.S’s broadside chip controls may be starting to bite.
Trump Administration Asks Top China Export Policy Official to Resign, Sources Say
WASHINGTON (Reuters) – The Trump administration has asked a senior Commerce Department official overseeing export restrictions on China to resign, three people familiar with the matter said. Matthew …
China: Manufacturers should make use of all legal means
Huawei’s boss asserts that China’s chip production is making progress. Xi Jinping wants to exploit all opportunities for market access.
Dr. Scott Gottlieb says he’s not too concerned on reports of a new coronavirus in China
Former FDA Commissioner Dr. Scott Gottlieb joins ‘Closing Bell’ to discuss reports of a new coronavirus in China.
New World Development flags up to $875 million interim loss amid China’s property woes
(Reuters) -Hong Kong-based property developer New World Development said on Friday it expects to swing to a loss of up to HK$6.80 billion ($875.07 million) for the first half of fiscal 2025 on lower …
New coronavirus ‘with pandemic potential’ discovered in China
A newly identified coronavirus in China might emerge and have the potential to spread through humans. Similar to the early days of Covid, researchers at the Wuhan Institute of Virology discovered a …
China trade envoy raises “serious concerns” with US Treasury Secretary in first call
The talks came shortly after Trump imposed additional tariffs on imports from China over its alleged role in the deadly fentanyl trade, which Beijing has pushed back against. “Secretary Bessent …
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
By selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially resuming development of roxadustat in another indication.
China Says US Ally Expelled From Disputed Territory
The encounter followed Tuesday’s near collision between an intercepting Chinese military helicopter and a Philippine turboprop.
China Market Update: Alibaba Goes Ballistic, Finance Minister Talks Consumption, Week In Review
Asian equities ended a positive week on a high note, led by Hong Kong and Mainland China-listed growth stocks following Alibaba’s financial results, which were reported after the close in Hong Kong …
ADVERTISEMENT
